| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.002 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |